High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.
| Image |  |
|---|---|
| Description | scientific article published in November 2007 |
| Author/s |
author: Giovanni Martinelli Pier Francesco Ferrucci Giovanni Paganelli |
| Publication date | November 1, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |